Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Dodel

Showing results (171-180 of 250) with videos related to

Pageof 25
Sort By:
Cerebrovascular Diseases (Basel, Switzerland)|August 20, 2010
Health-related quality of life in patients with subarachnoid haemorrhageBernhard Meyer, Florian Ringel, Yaroslav Winter, et al.
Neuro-Degenerative Diseases|June 5, 2010
Costs of Parkinson's disease and antiparkinsonian pharmacotherapy: an Italian cohort studyYaroslav Winter, Sonja von Campenhausen, Jens P Reese, et al.
Journal of the American Medical Directors Association|July 30, 2020
Characteristics of Patients with Late-Stage Parkinsonism Who are Nursing Home Residents Compared with those Living at HomeAlice Hosking, Adrianus A L J Hommel, Stefan Lorenzl, et al.
Journal of Neurology|February 9, 2010
Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's diseaseOliver Riedel, Jens Klotsche, Annika Spottke, et al.
Journal of Alzheimer'S Disease : JAD|August 31, 2011
Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settingsJens Peter Reese, Philipp Hessmann, Greta Seeberg, et al.
Health and Quality of Life Outcomes|March 19, 2013
Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's diseaseJudith Dams, Jens Klotsche, Bernhard Bornschein, et al.
Journal of Neurology|January 22, 2008
Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD)Oliver Riedel, Jens Klotsche, Annika Spottke, et al.
Journal of Neurology|April 12, 2011
Cost-of-illness in multiple system atrophy and progressive supranuclear palsyYaroslav Winter, Maria Stamelou, Nicole Cabanel, et al.
Journal of Neurology|May 1, 2012
Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adultsHajo M Hamer, Richard Dodel, Adam Strzelczyk, et al.
Neuro-Degenerative Diseases|May 18, 2011
Health-related quality of life in multiple system atrophy and progressive supranuclear palsyYaroslav Winter, Annika E Spottke, Maria Stamelou, et al.
Pageof 25

Showing results (171-180 of 250) with videos related to

Sort By:
Pageof 25
Cerebrovascular Diseases (Basel, Switzerland)|August 20, 2010
Health-related quality of life in patients with subarachnoid haemorrhageBernhard Meyer, Florian Ringel, Yaroslav Winter, et al.
Neuro-Degenerative Diseases|June 5, 2010
Costs of Parkinson's disease and antiparkinsonian pharmacotherapy: an Italian cohort studyYaroslav Winter, Sonja von Campenhausen, Jens P Reese, et al.
Journal of the American Medical Directors Association|July 30, 2020
Characteristics of Patients with Late-Stage Parkinsonism Who are Nursing Home Residents Compared with those Living at HomeAlice Hosking, Adrianus A L J Hommel, Stefan Lorenzl, et al.
Journal of Neurology|February 9, 2010
Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's diseaseOliver Riedel, Jens Klotsche, Annika Spottke, et al.
Journal of Alzheimer'S Disease : JAD|August 31, 2011
Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settingsJens Peter Reese, Philipp Hessmann, Greta Seeberg, et al.
Health and Quality of Life Outcomes|March 19, 2013
Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's diseaseJudith Dams, Jens Klotsche, Bernhard Bornschein, et al.
Journal of Neurology|January 22, 2008
Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD)Oliver Riedel, Jens Klotsche, Annika Spottke, et al.
Journal of Neurology|April 12, 2011
Cost-of-illness in multiple system atrophy and progressive supranuclear palsyYaroslav Winter, Maria Stamelou, Nicole Cabanel, et al.
Journal of Neurology|May 1, 2012
Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adultsHajo M Hamer, Richard Dodel, Adam Strzelczyk, et al.
Neuro-Degenerative Diseases|May 18, 2011
Health-related quality of life in multiple system atrophy and progressive supranuclear palsyYaroslav Winter, Annika E Spottke, Maria Stamelou, et al.
Pageof 25